GleamWall
中文EN

Largest insider buys

Open-market buys (Form 4 code P) filed in the last 30 days, by amount. Directors, officers and major holders buying their own company's stock with their own money is usually seen as a stronger signal than selling.

Last 7 daysLast 30 daysLast 90 days

Free users see the top 10. Pro shows the top 100, per-stock insider trades and API access. 🔒

FiledTradedTickerCompanyInsiderRoleTypeSharesAvg. priceAmountShares after
2026-11-032026-10-30 MGMMGM Resorts International Meister Keith A. Director Open-market buy 1,745,592$29.64 $51.74M 7,093,570
2026-11-022026-10-29 ROLROLLINS INC LOR INC 10% owner Open-market buy 1,444,402$34.59 $49.96M 146,728,468
2026-11-022026-10-29 ROLROLLINS INC R. Randall Rollins Voting Trust U/A dated August 25, 1994 10% owner Open-market buy 1,444,402$34.59 $49.96M 146,728,468
2026-11-032026-10-30 BBTXBambusa Therapeutics, Inc. RA CAPITAL MANAGEMENT, L.P. +5 owners Director / 10% owner Open-market buy 2,953,820$15.79 $46.64M 1,495,971
2026-11-092026-11-05 NFRX2023 ETF Series Trust Harrison Street Real Assets Fund LLC 10% owner Open-market buy 1,712,121$26.40 $45.20M 5,915,293
2026-11-122026-11-10 NFRX2023 ETF Series Trust Harrison Street Real Assets Fund LLC 10% owner Open-market buy 1,670,420$26.64 $44.50M 8,518,690
2026-11-042026-11-03 KNOPKNOT Offshore Partners LP Seglem Trygve Director Open-market buy 2,083,333$20.88 $43.50M 3,541,666
2026-11-172026-11-13 PEPGPepGen Inc. RA CAPITAL MANAGEMENT, L.P. +5 owners Director / 10% owner Open-market buy 8,625,000$5.00 $43.12M 27,179,273
2026-10-272026-10-23 LYCALycia Therapeutics, Inc. Venrock Healthcare Capital Partners III, L.P. +9 owners 10% owner Open-market buy 2,045,440$18.41 $37.65M 6,825,233
2026-11-062026-11-04 MDGLMADRIGAL PHARMACEUTICALS, INC. BAKER BROS. ADVISORS LP +6 owners Director Open-market buy 91,806$381.49 $35.02M 2,040,682

Multiple transactions in one filing are combined. Obviously wrong filings (e.g. total amount entered as the price) are excluded.